A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
The Genome Project-Write researchers are meeting again, but ScienceInsider notes that the effort is lacking funds.
The company, which is collaborating with Myeloma Crowd, will use the newly-licensed minicircle DNA technology to develop therapies for multiple myeloma.
In Science this week: a suite of studies from the Synthetic Yeast genome Project.
International research teams collaborated to create five fully functioning synthetic yeast chromosomes, taking them one step closer to a whole synthetic genome.
The collaborators hope initial research in canines can be a proving ground for synthetic viruses designed to kill particular tumors, perhaps even in humans.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.
In Science this week: effort to reduce E. coli genome, and more.
The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.
James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.
Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.
In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.